1. Home
  2. Analysis
  3. Micafungin
  4. Pseudomonas-infection

Micafungin and Pseudomonas infection - a phase IV clinical study of FDA data

Summary:

Pseudomonas infection is reported as a side effect among people who take Micafungin (micafungin sodium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Tacrolimus, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Pseudomonas infection when taking Micafungin. It is created by eHealthMe based on reports of 6,557 people who have side effects when taking Micafungin from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Pseudomonas infection?

Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa) is found to be associated with 868 drugs and 1,063 conditions by eHealthMe. Check the latest studies of Pseudomonas infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

6,557 people reported to have side effects when taking Micafungin.
Among them, 38 people (0.58%) have Pseudomonas infection.

Could Micafungin cause Pseudomonas infection?

Among these 38 people:

How long have people been on Micafungin when they have Pseudomonas infection? *

  • < 1 month: 42.86 %
  • 1 - 6 months: 57.14 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pseudomonas infection when taking Micafungin? *

  • female: 43.24 %
  • male: 56.76 %

What is the age of people who have Pseudomonas infection when taking Micafungin? *

  • 0-1: 0.0 %
  • 2-9: 5.56 %
  • 10-19: 8.33 %
  • 20-29: 22.22 %
  • 30-39: 25.0 %
  • 40-49: 2.78 %
  • 50-59: 8.33 %
  • 60+: 27.78 %

What are other drugs people take besides Micafungin? *

  1. Tacrolimus: 15 people, 39.47%
  2. Prednisolone: 10 people, 26.32%
  3. Methotrexate: 9 people, 23.68%
  4. Vancomycin: 9 people, 23.68%
  5. Zovirax: 8 people, 21.05%
  6. Ursodiol: 8 people, 21.05%
  7. Prednisolone Acetate: 7 people, 18.42%
  8. Ifosfamide: 7 people, 18.42%
  9. Hydrocortisone Sodium Succinate: 7 people, 18.42%
  10. Glutathione: 7 people, 18.42%

What are other side effects people have besides Pseudomonas infection? *

  1. Enterococcal Infection: 10 people, 26.32%
  2. Diarrhea: 9 people, 23.68%
  3. Fungal Infection: 9 people, 23.68%
  4. Nausea (feeling of having an urge to vomit): 9 people, 23.68%
  5. Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract): 8 people, 21.05%
  6. Scedosporium Infection (a filamentous fungus which occasionally causes infections in humans): 8 people, 21.05%
  7. Pneumonia: 8 people, 21.05%
  8. Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 8 people, 21.05%
  9. Renal Impairment (severely reduced kidney function): 8 people, 21.05%
  10. Infection: 8 people, 21.05%

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 8 people, 21.05%
  2. White Blood Cell Count Abnormal: 5 people, 13.16%
  3. Ewing's Sarcoma Recurrent (malignant small, round, blue cell tumour- recurrent): 5 people, 13.16%
  4. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 10.53%
  5. Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 3 people, 7.89%
  6. Pain: 3 people, 7.89%
  7. Immunodeficiency Disorders: 3 people, 7.89%
  8. Depression: 2 people, 5.26%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.26%
  10. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and have Pseudomonas infection?

- Check whether Pseudomonas infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micafungin:

Pseudomonas infection treatments and more:

How severe was Pseudomonas infection and when was it recovered:

Expand to all the drugs that have ingredients of micafungin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micafungin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pseudomonas infection:

Browse all the conditions that are associated with Pseudomonas infection:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on micafungin sodium (the active ingredients of Micafungin) and Micafungin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.